European Society of Oncology Pharmacy (ESOP)

What European Society of Oncology Pharmacy (ESOP) does

ESOP (European Society of Oncology Pharmacy) is a Hamburg-headquartered, non-profit professional society founded in 2000 that represents oncology pharmacists across Europe and internationally. It is the leading pan-European body dedicated specifically to oncology pharmacy and operates with a small core team of 16 employees c/o DGOP e.V.

Its core offerings span four areas: (i) education — annual EUSOP and ECOP conferences, the International Workshop (ExCOP), international e-learnings, and national training programs delivered through partner societies; (ii) standards and publications — the QuapoS quality assurance guidelines (current version 7), the peer-reviewed European Journal of Oncology Pharmacy (EJOP), and position statements on clinical practice topics such as in-use stability of reconstituted parenteral medicines; (iii) safety initiatives — Clean Working, Spill Kits, and the Yellow Hand program including the Yellow Hand Award and Monique-Ackermann-Award; and (iv) patient and policy resources — multilingual patient information leaflets for oral cancer drugs (14+ languages), working groups on oral cancer drugs and clean working, and engagement with the European Parliament and Commission, including EU4Health. The technology stack is intentionally lightweight, built on the esop.li website for member services, e-learning delivery, document distribution, and the EJOP archive library.

ESOP's business model is a recurring annual membership fee structure. In countries with a national oncology pharmacy society (30+ countries including DGOP in Germany, SFPO in France, and ASOP in Austria), the national partner pays ESOP fees on behalf of its members; in countries without a national partner, individuals pay directly at €5 per year (calendar-year basis, January 1 to December 31, paid by credit card or bank transfer in EUR). Ancillary revenue comes from conferences, publications, and project-related activities. There are no funding rounds, no external investors, and no disclosed enterprise sponsors. Customer segments span oncology pharmacists (primary), hospital pharmacies and healthcare institutions, and patients/advocates benefiting from the leaflet program.

Name

European Society of Oncology Pharmacy (ESOP)

Legal name

European Society of Oncology Pharmacy (ESOP)

Website

https://esop.li

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

ESOP is a Hamburg-based non-profit professional society, founded in 2000, that sets standards, delivers education, and runs the EJOP journal for oncology pharmacists across Europe and internationally via 30+ national partner societies.

Ownership category

akta.pro rank

Product category

Professional Pharmacy Society Services

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro industry

PRIMARYHLAGALAM

KOL Engagement & Medical Education (Advisory Boards/CME Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

Keywords

• Oncology pharmacy education
• Professional pharmacy society
• Continuing medical education
• Medication safety guidelines
• Pharmacy quality standards

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Fees: ESOP generates revenue primarily through annual membership fees. For countries with national partner organizations, those organizations pay the ESOP membership fee on behalf of their members. For individuals in countries without a national partner organization, direct membership costs 5 EUR per year per person. The membership year runs from January 1st to December 31st. Payment options include credit card and bank transfer in Euros.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

ESOP is a non-profit professional membership society that delivers oncology pharmacy education, conferences (EUSOP, ECOP), peer-reviewed publications (EJOP), quality assurance standards (QuapoS), safety guidelines (Clean Working, Yellow Hand), and multilingual patient education resources to oncology pharmacists across Europe. The society operates through direct individual membership and through 30+ national oncology pharmacy society partners that recruit and enroll members on behalf of ESOP.

Product overview

ESOP is a professional society for oncology pharmacy, not a technology product company. Its offerings include educational conferences (EUSOP, ECOP), the European Journal of Oncology Pharmacy (EJOP), quality standards (QuapoS), patient information resources (oral cancer drug leaflets in multiple languages), specialized Working Groups, research projects (EPIC, ERQCC, ECO, MASHA), and safety initiatives (Clean Working, Yellow Hand, Spill Kits). These are professional development, educational, and clinical resources for oncology pharmacists, not software products with API integrations.

Differentiator

Problem solved

Functional benefit

Products and services

• EUSOP (European Symposium of Oncology Pharmacy) Annual international symposium and congress offering continuing education, scientific sessions, and networking for oncology pharmacists from Europe and globally. Includes the associated International Workshop (ExCOP).
• ECOP (European Conference on Oncology Pharmacy) European conference dedicated to oncology pharmacy practice, bringing together pharmacists, clinicians, and researchers across European countries.
• EJOP (European Journal of Oncology Pharmacy) Peer-reviewed scientific journal publishing research, case reports, and clinical findings in oncology pharmacy, with archived issues available in the ESOP library.
• QuapoS (Quality Assurance for Oncology Pharmacy Services) Pan-European quality assurance standard and commentary document governing oncology pharmacy practice, now at version 7, adopted by hospital pharmacies across ESOP's member countries.
• Patient Information Leaflets on Oral Cancer Drugs Multilingual standardized patient education leaflets on oral anticancer medications, provided to hospitals and cancer centers for use in patient counseling and home-handling safety.
• International E-Learnings Online educational modules covering oncology pharmacy topics for international members and pharmacists, delivered through the ESOP protected area.
• National Trainings Country-specific oncology pharmacy training programs coordinated and delivered in partnership with ESOP's national member societies.
• Yellow Hand Safety Initiative Pan-European safety initiative promoting safe handling of hazardous oncology drugs, including the Yellow Hand Award and Monique-Ackermann-Award recognition programs.
• Clean Working Initiative Standardized safety guideline program covering clean working practices for healthcare workers who compound and administer hazardous oncology drugs.
• ESOP Spill Kits Standardized spill response kit product for safe containment and cleanup of hazardous oncology drug spills in pharmacy and clinical settings.
• ESOP Membership Annual society membership providing oncology pharmacists with access to EJOP journal, QuapoS standards, e-learnings, conference discounts, working groups, and protected resources.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• DGOP (Deutsche Gesellschaft für onkologische Pharmazie)coreStrategic or Co-development PartnerDGOP is ESOP's German national member organization. ESOP is c/o DGOP e.V. (registered address). DGOP manages membership and coordinates German oncology pharmacists within the ESOP network. The President of ESOP, Klaus Meier, is associated with this organization.
• SFPO (Société Francaise de Pharmacie Oncologique)coreStrategic or Co-development PartnerSFPO is ESOP's French national member organization, representing French oncology pharmacists within the ESOP network. French members join through SFPO.
• National Oncology Pharmacy Societies (30+ countries)coreStrategic or Co-development PartnerESOP has established formal relationships with national oncology pharmacy societies in over 30 countries including Algeria, Austria, Belgium, Bulgaria, Chile, Congo, Croatia, Czech Republic, Egypt, Estonia, France, Germany, Greece, Hungary, Italy, Luxembourg, Mexico, Morocco, Netherlands, Poland, Portugal, North Macedonia, Romania, Serbia, Slovenia, South Africa, Spain, Switzerland, Thailand, Turkey, and Zimbabwe. These national societies serve as membership channels and coordinate ESOP activities nationally.
• European Parliament and European CommissionminorStrategic or Co-development PartnerESOP engages with European Parliament and European Commission on healthcare policy matters related to oncology pharmacy and cancer care. ESOP also participates in EU4Health initiatives and contributes to policy discussions affecting cancer care and medication safety across Europe.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• American Society of Health-System Pharmacists (ASHP): Large US professional society for hospital and health-system pharmacists with extensive practice standards, accreditation, and continuing education programs. ASHP is a broader incumbent that overlaps ESOP where oncology pharmacy intersects with hospital pharmacy practice.
• European Society for Medical Oncology (ESMO): Leading European professional society for medical oncology, organizing major congresses, guidelines, and education for cancer physicians. ESMO is a broader oncology incumbent whose physician-facing activities set the context in which ESOP operates and increasingly overlap in multidisciplinary cancer care.
• International Pharmaceutical Federation (FIP): Global federation of national pharmaceutical associations and pharmacists, representing the profession at the international level. FIP is a broader incumbent that overlaps ESOP in pharmacy workforce, education, and policy advocacy, though without ESOP's oncology specialization.
• American Society of Clinical Oncology (ASCO): The dominant US/global oncology society for clinicians, with extensive guidelines, education, and policy work. ASCO is a broader incumbent whose scale, accreditation, and educational offerings exceed ESOP's, and which ESOP members commonly interact with in cross-disciplinary oncology care.

Direct peers

• Hematology/Oncology Pharmacy Association (HOPA): US-based professional association for hematology/oncology pharmacists with annual conference, practice standards, and member education. HOPA is the principal North American counterpart and a directly comparable peer in mission, membership model, and educational programming.
• British Oncology Pharmacy Association (BOPA): UK national oncology pharmacy association offering conferences, education, and member services to oncology pharmacists. BOPA is a direct country-level analogue of the national societies that constitute ESOP's membership base, making it a close structural peer at the national scale.
• International Society of Oncology Pharmacy Practitioners (ISOPP): Global professional society for oncology pharmacy practitioners, running its own annual symposium, certification programs, and standards. ISOPP is the most direct functional peer to ESOP, differing mainly in geographic orientation (global vs. Europe-led) and slightly earlier focus on certification.
• Société Française de Pharmacie Oncologique (SFPO): ESOP's French national member organization representing French oncology pharmacists. SFPO is a direct country-level peer to DGOP and to other national societies in ESOP's network, providing a like-for-like comparison of how a national oncology pharmacy society is structured.
• Canadian Association of Pharmacy in Oncology (CAPhO): Canadian national association for oncology pharmacists, providing education, networking, and standards support. CAPhO is another national-society peer with a closely aligned mission and member-driven governance model.
• Deutsche Gesellschaft für onkologische Pharmazie (DGOP): ESOP's German national member organization that also acts as ESOP's c/o registered address. DGOP is both a functional peer (national oncology pharmacy society with own events and members) and ESOP's closest operational partner; it is the largest single national node in ESOP's network.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/165241266858252
• LinkedInlinkedin.com/company/european-society-of-oncology-pharmacy-esop

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Society of Oncology Pharmacy (ESOP)